Literature DB >> 20823408

Recurrent scrotal hemangiomas during treatment with sunitinib.

Giuseppe Tonini1, Salvatore Intagliata, Barbara Cagli, Francesco Segreto, Giuseppe Perrone, Andrea Onetti Muda, Daniele Santini, Paolo Persichetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20823408     DOI： 10.1200/JCO.2010.30.4865

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Authors:  Rena C Zuo; Andrea B Apolo; John J DiGiovanna; Howard L Parnes; Corrine M Keen; Swati Nanda; William L Dahut; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

2.  Cutaneous side effects associated with sunitinib: an analysis of 8 cases.

Authors:  Claire Vignand-Courtin; Caroline Martin; Christine Le Beller; Christina Mateus; Severine Barbault-Foucher; André Rieutord
Journal:  Int J Clin Pharm       Date:  2012-03-17

Review 3.  Zebrafish Cancer Predisposition Models.

Authors:  Kim Kobar; Keon Collett; Sergey V Prykhozhij; Jason N Berman
Journal:  Front Cell Dev Biol       Date:  2021-04-27

4.  Case Report: Targeted Therapy for Metastatic Solid Pseudopapillary Neoplasm of the Pancreas With CTNNB1 and PTEN Mutations.

Authors:  Xinbo Wang; Daojun Zhu; Wei Bao; Min Li; Sizhen Wang; Rongxi Shen
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

5.  A Case Report of Multiple Capillary Hemangioma in a Chronic Myeloid Leukemia Patient Taking Tyrosine Kinase Inhibitors.

Authors:  Hyun Jeong Byun; Donghwi Jang; Jongeun Lee; Se Jin Oh; Youngkyoung Lim; Ji-Hye Park; Jong Hee Lee; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

6.  Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish.

Authors:  Suma Choorapoikayil; Bart Weijts; Rianne Kers; Alain de Bruin; Jeroen den Hertog
Journal:  Dis Model Mech       Date:  2013-05-29       Impact factor: 5.758
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.